Tetrahedron Letters
3
8. (a) Yadav, J. S.; Palash Dutta,; Bogonda Ganganna,
Eedubilli Srinivas. Eur. J. Org. Chem. 2015, 6891–6899;
(b) Christopher M. Schneider,; Wei Li, Kriangsak
Khownium,; Gerald H,; Lushington,; Gunda I. Georg.
ChemMedChem. 2016, 11, 1600–1616.
9. J. Alberto Marco,; Jorge García-Pla,; Miguel Carda,; Juan
Murga,; Eva Falomir,; Chiara Trigili,; Sara Notararigo c,;
J. Fernando Díaz c,; Isabel Barasoain. European Journal of
Medicinal Chemistry. 2011, 46, 1630-1637.
10. D. B. Dess and J. C. Martin, J. Am. Chem. Soc. 1991, 113,
277–7287.
11. (a) Rui Fu, Jie Chen, Lu-Chuan Guo, Jian-Liang Ye, Yuan-
Ping Ruan, Pei-Qiang Huang, Org. Lett. 2009, 11,
5242-5245; (b) P. Sankara Rao,; P. Srihari. Org. Biomol.
Chem., 2016, 14, 9629–9638.
At this stage protection of the required secondary alcohol 9 as
its MOM ether was carried out using MOMCl, in the presence
o
of DIPEA in CH2Cl2 at 0 C to RT for 12 h, furnished the
MOM ether 21 in good yield. Having prepared the key
intermediate in hand we next turned our attention to RCM
reaction, accordingly the resulting MOM ether 21 was then
subjected to undergo ring-closing metathesis using Hoveyda-
Grubbs second generation catalyst in refluxing toluene lead to
the formation of the desired lactone 22 in 66% yield.14 Finally
deprotection of TMS group in lactone 22 using TBAF in THF
o
at -20 C for 10 min furnished the required alkyne 7 in 86%
yield.15 (Scheme 5)
12. (a) Rychnovsky, S. D.; Skalitxky, D. J. Tetrahedron
Letters. 1990, 31, 945-948; (b) D. A. Evans, D. L.
Rieger J. R. Gage, Tetrahedron Letters. 1990, 31,
7099–7100.
Conclusions
In conclusion we have achieved the pivotal C1 - C13 and C14
- C22 fragments of the antitumor natural product phostriecin.
The synthesis of an advanced intermediate 7 from compound
13 in 11 steps with 10% overall yield. The key steps involved
are Wittig reaction, Browns’ alkoxyallylboration, CBS
reduction and Rring-closing metathesis. Further research was
under progress for the completion of total synthesis of
phostriecin and will be reported in due course.
13. (a) K. A. Parker, M. W. Ledeboer, J. Org. Chem. 1996,
61, 3214-3217; (b) E. J. Corey, R. K. Bakshi, S. Shibata, J.
Am. Chem. Soc. 1987, 109, 5551-5553.
14. (a) S. Michaelis, S. Blechert, Org. Lett. 2005, 7, 5513-
5516; (b) Grubbs, R. H; Chang, S. Tetrahedron. 1998, 54,
4413–4450; (c) Schwab, P.; France, M. B.; Ziller, J. W.;
Grubbs, R. H. Angew. Chem., Int. Ed. Engl. 1995, 34,
2039–2041; (d) Schwab, P.; Grubbs, R. H.; Ziller, J. W. J.
Am. Chem. Soc. 1996, 118, 100–110.
15. Cai, C.; Vasella, A.; Helv. Chem. Acta, 1995, 78, 732.
16. The side chain C14- C22 fragment 21 which in turn was
prepared from trans-2-Octenal in two steps according to a
literature procedure. (a) Chao Shu , Yong-Heng
Wang , Cang-Hai Shen , Peng-Peng Ruan , Xin Lu , Long-
Wu Ye. Organic Letters 2016 18 (13), 3254-3257. (b)
Corey, E. J.; Fuchs, P. L. Tetrahedron Letters 1972, 13,
3769–3772. (c) Rosenthal, M.; Li, L.;. Hernandez, J.J.;
Zhu, X.; Ivanov, D.A.; Mçller,M.; Chem. Eur. J. 2013, 19,
4300 – 4307
Acknowledgements
G.C.R., C.H.S.K. thanks Council of Scientific and Industrial
Research (CSIR), New Delhi, India, for the award of
fellowship. VSN, KMK thanks UGC. JSY thanks CSIR and
DST, New Delhi for Bhatnagar and J. C. Bose Fellowships
respectively.
References and notes:
Br
1. Ohkuma, H.; Naruse, N.; Nishiyama, Y.; Tsuno, T.;
Hoshino, Y.; Sawada, Y.; Konishi, M.; Oki, T. J. Antibiot.
1992, 45, 1239-1249.
TPP,CBr4,
CH2Cl2, 0 oC-rt
NBS,Acetone
-20 oC, 82%
n-BuLi,-78 oC,
O
THF 78%
12
2. (a) Swingle, M.; Ni, L.; Honkanen, R. E. Methods Mol.
Biol. 2007, 365, 23. (b) Virshup, D. M.; Shenolikar, S.
Mol. Cell 2009, 33, 537-545. (c) McConnell, J. L;
Wadzinski, B. E. Mol. Pharmacol. 2009, 75, 1249-1261.
3. (a) Lewy, D. S.; Gauss, C. M.; Soenen, D. R.; Boger, D. L.
Curr. Med.Chem. 2002, 9, 2005-2032. (b) For related
natural products see ref 4 and ref 5 and references cited
therin.
10
8
Supplementary Material: Experimental procedures, spectral
data, copies of 1H NMR and 13C NMR spectra available.
4. Burke, C. P.; Haq, N.; Boger, D. L. J. Am. Chem. Soc.
2010, 132, 2157-2159.
5. Burke,; C. P.; Swingle,; M.R.; Honkanen,; R.E.; Boger,;
D. L. J. Org. Chem. 2010, 75, 7505-7513.
6. The known diol compound 13 was readily prepared from
commercially available 1,3-propanediol as per the
literature procedure. (a) Chandrasekhar, S,; Sathish, K,;
Pavan Kumar Reddy, G; Prathama S. Mainkar.
Tetrahedron: Asymmetry. 2014, 25, 348–355. (b) Yadav, J.
S; Eppa Gyanchander, Anand Kumar Mishra, Peddapuram
Adithya, Saibal Das. Tetrahedron Letters. 2013, 54, 5879-
5882.
OH
O
S
OH
BnO
N
BnO
OH
HO
OH
S
13
Ph
7. (a) Trost, B.M.; Weiss, A.H; Angew. Chem. Int. Ed. 2007,
46, 7664 –7666; (b) Birakishore, P.; Srinivas Reddy, D.;
Mohapatra, D. K. Eur. J. Org. Chem. 2015, 542–547.